Sanjay Mehrota, CEO, Micron
Scott Mlyn | CNBC
Check out the companies making headlines after-hours Tuesday:
Regeneron Pharmaceuticals — The pharmaceutical company said trial data for its coronavirus antibody cocktail showed it reduced “viral levels and improved symptoms in non-hospitalized COVID-19 patients.” Regeneron shares were halted in after-hours trading.
Micron Technology — Micron shares rose more than 1% in after-hours trading after the chip maker reported quarterly results that beat analyst expectations. The company posted a profit of $1.08 per share on revenue of $6.06 billion. Analysts expected earnings per share of $5.89 billion. Micron also issued stronger-than-forecast earnings